Olmesartan for the delay or prevention of Microalbuminuria in Type 2 Diabetes

Saved in:

Bibliographic Details
Main Authors:	Haller, Hermann (Author) , Ito, Sadayoshi (Author) , Izzo, Joseph L. (Author) , Januszewicz, Andrzej (Author) , Katayama, Shigehiro (Author) , Menne, Jan (Author) , Mimran, Albert (Author) , Rabelink, Ton J. (Author) , Ritz, Eberhard (Author) , Ruilope, Luis M. (Author) , Rump, Lars C. (Author) , Viberti, Giancarlo (Author)
Format:	Article (Journal)
Language:	English
Published:	March 10, 2011
In:	The New England journal of medicine Year: 2011, Volume: 364, Issue: 10, Pages: 907-917
ISSN:	1533-4406
DOI:	10.1056/NEJMoa1007994
Online Access:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1056/NEJMoa1007994 Verlag, lizenzpflichtig, Volltext: https://www.nejm.org/doi/10.1056/NEJMoa1007994
Author Notes:	Hermann Haller, Sadayoshi Ito, Joseph L. Izzo, Andrzej Januszewicz, Shigehiro Katayama, Jan Menne, Albert Mimran, Ton J. Rabelink, Eberhard Ritz, Luis M. Ruilope, Lars C. Rump, and Giancarlo Viberti for the ROADMAP Trial Investigators

Similar Items